Trial · NCT02502266
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Arm I (Reference Regimen) | 173 | |
| Overall Study | STARTED | Arm II (Cediranib Maleate, Olaparib) | 167 | |
| Overall Study | STARTED | Arm III (Cediranib Maleate) | 170 | |
| Overall Study | STARTED | Arm IV (Olaparib) (Phase II Only) | 52 | |
| Overall Study | STARTED | Arm V (Arm I Regimen: JP Patients Enrolled After P3 Cutoff) | 5 | |
| Overall Study | STARTED | Arm VI: (Arm II Regimen: JP Patients Enrolled After P3 Cutoff) | 8 | |
| Overall Study | STARTED | Arm VII: (Arm III Regimen: JP Patients Enrolled After P3 Cutoff) | 7 | |
| Overall Study | COMPLETED | Arm I (Reference Regimen) | 124 | |
| Overall Study | COMPLETED | Arm II (Cediranib Maleate, Olaparib) | 146 | |
| Overall Study | COMPLETED | Arm III (Cediranib Maleate) | 139 | |
| Overall Study | COMPLETED | Arm IV (Olaparib) (Phase II Only) | 0 | |
| Overall Study | COMPLETED | Arm V (Arm I Regimen: JP Patients Enrolled After P3 Cutoff) | 3 | |
| Overall Study | COMPLETED | Arm VI: (Arm II Regimen: JP Patients Enrolled After P3 Cutoff) | 5 | |
| Overall Study | COMPLETED | Arm VII: (Arm III Regimen: JP Patients Enrolled After P3 Cutoff) | 6 | |
| Overall Study | NOT COMPLETED | Arm I (Reference Regimen) | 49 | |
| Overall Study | NOT COMPLETED | Arm II (Cediranib Maleate, Olaparib) | 21 | |
| Overall Study | NOT COMPLETED | Arm III (Cediranib Maleate) | 31 | |
| Overall Study | NOT COMPLETED | Arm IV (Olaparib) (Phase II Only) | 52 | |
| Overall Study | NOT COMPLETED | Arm V (Arm I Regimen: JP Patients Enrolled After P3 Cutoff) | 2 | |
| Overall Study | NOT COMPLETED | Arm VI: (Arm II Regimen: JP Patients Enrolled After P3 Cutoff) | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02502266/flow